Funding for this research was provided by:
National Heart, Lung, and Blood Institute (K23HL138190)
Received: 24 July 2017
Accepted: 30 January 2018
First Online: 8 February 2018
Ethics approval and consent to participate
: This study was approved by the University of Chicago Institutional Review Board (protocol #14163). All patients provided written informed consent for this study.
: Not applicable
: JMO has received grants from the American Thoracic Society, Boehringer Ingelheim and the American Lung Association, and has received consulting and speaking fees from Genentech and Boerhinger Ingelheim, outside the submitted work. LJW, AA, KL, AH, SM, SH and LC have nothing to disclose. JHC has received consulting and speaking fees from Genentech outside the submitted work. RV has received a grant from Genentech outside the submitted work. MES has institutional grants from the NIH and Boehringer Ingelheim for the conduct of clinical trials in IPF. She has received honoraria for serving on a Data Monitoring Committee for Boehringer Ingelheim and an advisory board for Boehringer Ingelheim and Genentech outside the submitted work. IN has received honoraria for advisory boards with Boehringer Ingelheim, InterMune, Anthera outside the submitted work. He has also received speaking honoraria from GSK and receives consulting fees for Immuneworks outside the submitted work. He also has study contracts with the NIH, Stromedix, Sanofi, and BI for the conduct of clinical trials in IPF.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.